| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
| 07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
| 07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
| 07/14/1998 | US5780498 Endothelin receptor antagonists |
| 07/14/1998 | US5780495 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/14/1998 | US5780487 S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
| 07/14/1998 | US5780468 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
| 07/14/1998 | US5780449 Oligonucelotides; nucleotide sequences |
| 07/14/1998 | US5780286 Arginase II |
| 07/14/1998 | US5780265 Kunitz type plasma kallikrein inhibitors |
| 07/14/1998 | CA2043228C Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/1998 | WO1998029415A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 07/09/1998 | WO1998029411A1 Sulfonamide compounds having 5-ht receptor activity |
| 07/09/1998 | WO1998029119A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | WO1998029107A2 Poly(diallylamine)-based bile acid sequestrants |
| 07/09/1998 | WO1998028980A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | WO1998022099A3 New use of creatine |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2276394A1 Poly(diallylamine)-based bile acid sequestrants |
| 07/09/1998 | CA2276150A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2276081A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2275668A1 Sulfonamide compounds having 5-ht receptor activity |
| 07/09/1998 | CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/08/1998 | EP0852226A1 Pyrimidine derivatives |
| 07/08/1998 | EP0852225A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient |
| 07/08/1998 | EP0852142A1 Diamines in the treatment of arrhythmia |
| 07/08/1998 | EP0851871A1 Inhibition of tumor growth |
| 07/08/1998 | EP0851759A1 Compounds and methods |
| 07/08/1998 | EP0736023B1 Indole, indoline and quinoline derivatives with 5ht 1d (anti-depressive) activity |
| 07/08/1998 | EP0730589B1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 07/08/1998 | CN1187190A Amino acid derivatives of substituted quinoxaline 2, 3 -dione derivativesa as glutamate receptor antagonists |
| 07/08/1998 | CN1187132A Processed ginseng having enhanced pharmacological effect |
| 07/08/1998 | CN1187129A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 07/08/1998 | CN1186682A Method for preparing angiocardiopathy medicine |
| 07/08/1998 | CN1039008C Dual action inhibitors in angiotensin invertase and neutral endopeptidase |
| 07/07/1998 | US5777114 Spiro heterocycle-imidazo 1,2-a!indeno 1,2-e!pyrazine!-4'-ones, preparation thereof and drugs containing same |
| 07/07/1998 | US5776980 Substituted benzenesulfonylureas and -thioureas-process for their preparation and their use as pharmaceuticals |
| 07/07/1998 | US5776979 Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 07/07/1998 | US5776978 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 07/07/1998 | US5776964 Hypotensive agents; anticholesterol agents; cardiovascular disorders |
| 07/07/1998 | US5776951 Anticholesterol agent |
| 07/07/1998 | US5776949 2-(1H) quinolinone compounds |
| 07/07/1998 | US5776940 Compounds for treatment of septic shock, antiinflammatory and antiallergens |
| 07/07/1998 | US5776911 Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia |
| 07/07/1998 | US5776903 Replacing peptide bond with phosphine bond |
| 07/07/1998 | US5776895 Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock |
| 07/07/1998 | US5776734 DNA encoding the β subunit of a mammalian maxi-K potassium channel |
| 07/07/1998 | US5776729 Human G-protein receptor HGBER32 |
| 07/07/1998 | US5776704 Method of detecting angiogenic protein |
| 07/07/1998 | US5776504 Magnesium taurate for prevention and treatment of pre-eclampsia/eclampsia |
| 07/07/1998 | CA2133963C Novel mercaptoacetylamido pyridazo¬1,2|pyridazine, pyrazolo¬1,2|pyridazine, pyridazo¬1,2-a|¬1,2|diazepine and pyrazolo¬1,2-a|¬1,2|diazepine derivatives useful as inhibitors of enkephalinase and ace |
| 07/02/1998 | WO1998028621A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | WO1998028427A1 Ob fusion protein compositions and methods |
| 07/02/1998 | WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | WO1998028300A1 Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments |
| 07/02/1998 | WO1998028293A1 Indane or dihydroindole derivatives |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028290A1 Indane or dihydroindole derivatives |
| 07/02/1998 | WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 07/02/1998 | WO1998028276A1 Triarylethanes useful as pde iv inhibitors |
| 07/02/1998 | WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 07/02/1998 | WO1998028257A1 Aromatic amine derivatives having nos inhibitory effect |
| 07/02/1998 | WO1998027998A1 Remedies for cerebral ischemic diseases |
| 07/02/1998 | WO1998027995A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | WO1998027974A1 Antidiabetic agents |
| 07/02/1998 | WO1998027932A2 Cerebellum and embryo specific protein |
| 07/02/1998 | WO1998027930A2 New use of aminopiperazine derivatives |
| 07/02/1998 | CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
| 07/02/1998 | CA2275933A1 Aromatic amine derivatives having nos inhibiting action |
| 07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |
| 07/02/1998 | CA2275540A1 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275436A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | CA2275394A1 Antidiabetic agents |
| 07/02/1998 | CA2275318A1 New use of aminopiperazine derivatives |
| 07/02/1998 | CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | CA2275183A1 Ob fusion protein compositions and methods |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850301A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 07/01/1998 | EP0850236A1 Piperazino derivatives as neurokinin antagonists |
| 07/01/1998 | EP0850235A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 07/01/1998 | EP0850062A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 07/01/1998 | EP0814800A4 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186502A Compositions and methods for inhibiting thrombogenesis |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186439A Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
| 07/01/1998 | CN1185974A Human calcium degrading gene concerned peptide fatty composite and preparation thereof |
| 07/01/1998 | CN1185963A Medicine for coronary heart disease and production thereof |